We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
Section 14 consents
Search consents to import, supply or export therapeutic goods that do not comply with standards.
Medicines and other therapeutic goods must comply with applicable standards to be supplied in Australia.
Under the Therapeutic Goods Act 1989 prior consent must be given under sections 14 and 14A of the Act to the import, export or supply of therapeutic goods that do not comply with an applicable standard. The Secretary can impose conditions on the consent under section 15 of the Act.
The records below include information about these decisions, and any subsequent review of such decisions. All records below which relate to a single consent decision will have the same consent number.
Information about decisions made before 29 January 2016 are on the Federal Register of Legislation website.
For guidance on applying for consent see Consent to import, supply or export therapeutic goods that do not comply with standards - information for industry
In July 2020, TGA created a special consent process for prescription medicine manufacturers experiencing difficulties in introducing new TGO91 labels into their manufacturing process due to COVID-19. These decisions are displayed in a separate database: Database of consents for prescription medicines that do not comply with TGO 91 labelling due to COVID-19.
Filter results
You can narrow down the results using the filters.
Therapeutic good type
- Prescription medicines (1524)
- Listed complementary medicines (952)
- Over-the-counter medicines (254)
- Blood, tissues, and biologicals (212)
- Other therapeutic goods non-approved (87)
- Registered complementary medicines (51)
- Other therapeutic goods registered (4)
- Other therapeutic goods listed (2)
- Listed Medicines (1)
Decision date
Search
-
Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective for all batches of the products released from 1 February 2024 until 31 January 2025.
-
Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective for all batches of the products released from 1 February 2024 until 31 January 2025.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to export while noncompliant with standards. The consent is effective from 1 February 2024 until further notice.
-
Section 14 consentConsent to supply while noncompliant with standards. The consent is effective from the 23/01/2024 until the date when TGO 102 sunsets which is 01 April 2029.
-
Section 14 consentConsent to supply while noncompliant with standards. The consent is effective from 23 January 2024 until the date when TGO 108 sunsets which is 1 October 2031.
-
Section 14 consentConsent to supply while noncompliant with standards. The consent is effective from 11 January 2024 until Batch number 1134831 is depleted or expired.
-
Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 10 January 2024 until 31 December 2024 until the current category 1 application is approved, whichever occurs first.
-
Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from the date of this letter until batch number 2855 is exhausted (approximately 12 weeks from the date of release).
-
Section 14 consentConsent to supply while noncompliant with standards. The consent is effective from 10 January 2024 until 31 March 2029 or until the criteria in BP Appendix XVI C. Efficacy of Antimicrobial Preservation for A. brasiliensis is revised, whichever occurs first.
-
Section 14 consentConsent to supply while noncompliant with standards. The consent is effective from 10 January 2024 until batch numbers BN 31213B & BN 31214B are depleted or expired.
-
Section 14 consentConsent to import and supply while noncompliant with standards. The consent is effective from 9 January 2024 until 30 September 2026.